VRDN
#2004
Viridian Therapeutics, Inc. - Common Stock
19.0 6 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.10%
Variación mensual
+18.53%
Variación en los últimos 6 meses
-41.32%
Cambio anual
-15.10%
Cierres anteriores
19.0 8
Open
19.0 6
Mínimo
19.0 6
High
19.0 6
Volumen
101
Financials
- Market Capitalization 1.96 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.07
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2001 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.78 USD | -2.31% | -1.33% | +17.59% | +112.17% | 1.98 B USD | ||
| 2003 |  ATAI AtaiBeckley Inc. - Common Stock | 5.36 USD | -5.47% | +2.88% | +30.10% | +35.70% | 1.97 B USD | ||
| 2011 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 39.80 USD | +1.56% | +4.24% | +22.46% | +109.47% | 1.94 B USD | ||
| 2013 |  NBTX Nanobiotix S.A. - ADSs | 39.96 USD | -4.03% | +2.62% | +16.74% | +666.99% | 1.93 B USD |